The changes in cell proliferation and the activation of the SRC/ERK pathway in prostate cancer cells upon stimulation with GDNF indicated that GDNF could also have an effect on the survival of prostate cancer in the context of cancer-directed therapeutics. This evidence concerns the gene GDNF and Familial prostate cancer.